Caffeine and amphetamine produce cross-sensitization to nicotine-induced locomotor activity in mice

被引:42
|
作者
Celik, E
Uzbay, IT [1 ]
Karakas, S
机构
[1] Gulhane Mil Med Acad, Fac Med, Dept Med Pharmacol, Psychopharmacol Res Unit, TR-06018 Ankara, Turkey
[2] Hacettepe Univ, Specializat Area Expt Psychol, Ankara, Turkey
关键词
amphetamine; caffeine; cross-sensitization; locomotor activity; mice; nicotine;
D O I
10.1016/j.pnpbp.2005.06.014
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Sensitization development is linked to the addictive potential of the drugs. The same mechanisms might play a role in sensitization development to the different addictive drugs. The aim of the study was to investigate the development of cross-sensitization to caffeine and amphetamine in nicotine-induced locomotor sensitization in mice. Caffeine (2.5 - 20 mg/kg), amphetamine (1 - 16 mg/kg) or saline were injected to Swiss-Webster mice and locomotor activity was recorded for 30 min. Nicotine (0.5-2 mg/kg) or saline were injected to mice and locomotor activity was recorded for 30 min. Process was applied for 19 days, every other day (10 sessions). Caffeine (5 mg/kg), amphetamine (4 mg/kg) or saline were challenged to the different groups of nicotine-sensitized mice 2 days later on the last nicotine injection, and locomotor activity was recorded. Repetitive injections of nicotine (0.5-2 mg) produced locomotor sensitization in mice. After caffeine and amphetamine challenge injections, locomotor activity of the nicotine-sensitized mice was found to be significantly higher than saline-pretreated mice. Saline challenge did not produce any significant effect in nicotine- or saline-pretreated mice. Our results suggest that a cross-sensitization developed to both caffeine and amphetamine in nicotine-sensitized mice. In conclusion, similar central mechanisms may be responsible for the development of addiction to these substances. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:50 / 55
页数:6
相关论文
共 50 条
  • [41] Stress-induced cross-sensitization to amphetamine is related to changes in the dopaminergic system
    Cruz, Fabio C.
    Marin, Marcelo Tadeu
    Leao, Rodrigo Molini
    Planeta, Cleopatra S.
    JOURNAL OF NEURAL TRANSMISSION, 2012, 119 (04) : 415 - 424
  • [42] Stress-induced cross-sensitization to amphetamine is related to changes in the dopaminergic system
    Fábio C. Cruz
    Marcelo Tadeu Marin
    Rodrigo Molini Leão
    Cleopatra S. Planeta
    Journal of Neural Transmission, 2012, 119 : 415 - 424
  • [43] Reciprocal cross-sensitization between amphetamine and salt appetite
    Clark, JJ
    Bernstein, IL
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2004, 78 (04) : 691 - 698
  • [44] Cross-sensitization between the locomotor stimulant effects of ethanol and those of morphine and cocaine in mice
    Lessov, CN
    Phillips, TJ
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2003, 27 (04) : 616 - 627
  • [45] Nicotine-induced locomotor activity is increased by preexposure of rats to prenatal stress
    Koehl, M
    Bjijou, Y
    Le Moal, M
    Cador, M
    BRAIN RESEARCH, 2000, 882 (1-2) : 196 - 200
  • [46] Loss of nicotine-induced behavioral sensitization in μ-opioid receptor knockout mice
    Yoo, JH
    Lee, SY
    Loh, HH
    Ho, IK
    Jang, CG
    SYNAPSE, 2004, 51 (04) : 219 - 223
  • [47] Effects of cocaine, nicotine, dizocipline and alcohol on mice locomotor activity: cocaine-alcohol cross-sensitization involves upregulation of striatal dopamine transporter binding sites
    Itzhak, Y
    Martin, JL
    BRAIN RESEARCH, 1999, 818 (02) : 204 - 211
  • [48] THE IMPORTANCE OF NUCLEUS-ACCUMBENS IN NICOTINE-INDUCED LOCOMOTOR-ACTIVITY
    FUNG, YK
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1990, 42 (08) : 595 - 596
  • [49] Serotonergic involvement in nicotine- and amphetamine-induced locomotor sensitization and disinhibition in the rat
    Olausson, P
    Engel, JA
    Söderpalm, B
    NORDIC JOURNAL OF PSYCHIATRY, 2000, 54 (02) : 99 - 100
  • [50] Adrenalectomy attenuates nicotine-induced dopamine release and locomotor activity in rats
    Shoaib, M
    Shippenberg, TS
    PSYCHOPHARMACOLOGY, 1996, 128 (04) : 343 - 350